DE3564907D1 - Utilization of the heteropolyanion (nasb9w21086)18- for the manufacture of a pharmaceutical composition for the treatment of aids and analogous syndromes - Google Patents

Utilization of the heteropolyanion (nasb9w21086)18- for the manufacture of a pharmaceutical composition for the treatment of aids and analogous syndromes

Info

Publication number
DE3564907D1
DE3564907D1 DE8585402392T DE3564907T DE3564907D1 DE 3564907 D1 DE3564907 D1 DE 3564907D1 DE 8585402392 T DE8585402392 T DE 8585402392T DE 3564907 T DE3564907 T DE 3564907T DE 3564907 D1 DE3564907 D1 DE 3564907D1
Authority
DE
Germany
Prior art keywords
heteropolyanion
aids
treatment
syndromes
analogous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585402392T
Other languages
English (en)
Inventor
Jean-Claude Chermann
Luc Montagnier
Etienne Vilmer
Dominique Dormont
Bruno Spire
Francoise Barre-Sinoussi
Willy Rozenbaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE3564907D1 publication Critical patent/DE3564907D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8585402392T 1984-12-03 1985-12-03 Utilization of the heteropolyanion (nasb9w21086)18- for the manufacture of a pharmaceutical composition for the treatment of aids and analogous syndromes Expired DE3564907D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67824084A 1984-12-03 1984-12-03

Publications (1)

Publication Number Publication Date
DE3564907D1 true DE3564907D1 (en) 1988-10-20

Family

ID=24721989

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19853542165 Withdrawn DE3542165A1 (de) 1984-12-03 1985-11-29 Medikament zur behandlung des syndroms der erworbenen immunschwaeche (aids) und entsprechende pharmazeutische zusammensetzungen
DE8585402392T Expired DE3564907D1 (en) 1984-12-03 1985-12-03 Utilization of the heteropolyanion (nasb9w21086)18- for the manufacture of a pharmaceutical composition for the treatment of aids and analogous syndromes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19853542165 Withdrawn DE3542165A1 (de) 1984-12-03 1985-11-29 Medikament zur behandlung des syndroms der erworbenen immunschwaeche (aids) und entsprechende pharmazeutische zusammensetzungen

Country Status (6)

Country Link
EP (1) EP0185584B1 (de)
JP (1) JPS61227525A (de)
AT (1) ATE37142T1 (de)
AU (1) AU589148B2 (de)
DE (2) DE3542165A1 (de)
IL (1) IL77188A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332940C (en) * 1986-08-07 1994-11-08 Henrich Hasko Paradies N-alkylated quaternary nitrogen-containing heterocycles
JP2707252B2 (ja) * 1987-08-03 1998-01-28 利博 山瀬 抗ウィルス剤
WO1990006756A1 (en) * 1988-12-16 1990-06-28 Terumo Kabushiki Kaisha Antiviral agent
JP2993674B2 (ja) * 1989-02-01 1999-12-20 利博 山瀬 抗後天性免疫不全症候群ウイルス剤
JPH0334931A (ja) * 1989-06-30 1991-02-14 Hokkaido Togyo Kk 抗レトロウイルス剤
DE4302053C1 (de) * 1993-01-26 1994-06-30 Gunther Dr Kuemel Pharmazeutische Zusammensetzung, die gegenüber Infektionen mit HIV-Viren prophylaktisch wirkt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (de) * 1973-07-27 1977-02-25 Anvar
GB1573002A (en) * 1975-12-10 1980-08-13 Anvar Antiviral agent
FR2334366A2 (fr) * 1975-12-10 1977-07-08 Anvar Application a titre d'agents antiviraux de composes d'heteropolyanions contenant du tungstene combine a de l'antimoine
FR2372633A2 (fr) * 1976-12-03 1978-06-30 Anvar Compose d'heteropolyanions contenant du tungstene combine a de l'antimoine, leur obtention et leurs applications

Also Published As

Publication number Publication date
AU589148B2 (en) 1989-10-05
DE3542165A1 (de) 1986-07-10
EP0185584B1 (de) 1988-09-14
IL77188A0 (en) 1986-04-29
JPS61227525A (ja) 1986-10-09
AU5058085A (en) 1986-07-17
JPH0262533B2 (de) 1990-12-26
ATE37142T1 (de) 1988-09-15
EP0185584A1 (de) 1986-06-25
IL77188A (en) 1989-03-31

Similar Documents

Publication Publication Date Title
DE3469342D1 (en) Pharmaceutical composition on the basis of valproic acid, and its manufacturing process
DE3473153D1 (en) Maleic acid copolymer, production thereof and scale-preventing agent containing the same
IL72420A0 (en) Aqueous vitamine solutions and their manufacture
DE3861709D1 (de) Anti-hiv-mittel und methode zu deren erzeugung.
IE831254L (en) Composition based on fluorochlorohydrocarbon,phosphatic acid¹ester and carboxylic acid.
ZA879011B (en) Variants of hirudin,their use and their preparation
DE3564907D1 (en) Utilization of the heteropolyanion (nasb9w21086)18- for the manufacture of a pharmaceutical composition for the treatment of aids and analogous syndromes
GB2208620B (en) Seals between ceramic articles or between ceramic articles and metal articles.
EP0200790A4 (de) Antineoplastisches mittel.
DE3162659D1 (en) 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof
AU1463888A (en) Nitrification-inhibiting agent
DE3264433D1 (en) Compositions on the basis of 5-hydroxy-tryptophane, manufacturing process and medicaments containing them
GB2151233B (en) 2,5-diketo-d-gluconic acid reductase
ZA858195B (en) 1,2,4-triazolo-carbamates and the acid addition salts thereof,processes for preparing them and pharmaceutical compositions
EP0229182A4 (de) Anordnung zur einstellung einer optischen faser.
AR245030A1 (es) Fabricacion de recipientes
JPS57169493A (en) 6-(2-amino-2-phenylacetamide)penicillanic acid 1,1-dioxopenicillanoyloxymethyl, manufacture and intermediate
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
PH25122A (en) Process for the manufacture of n.n.-(dibenzo-hexatrienylene) ureas
IT7925638A0 (it) Procedimento di confezionamento diprodotti in polvere o in granuli in imballaggi morbidi e installazione per la realizzazione di tale procedimento.
AR242780A1 (es) Procedimiento i.d.r. para la fabricacion de urea y aparato condensador.
JPS57159797A (en) Antiviral, manufacture and medicinal composition
JPS6434993A (en) Hydroxyacetonitrilephosphonic acid, manufacture and chelating agent and limiting agent therefrom
ES8401320A1 (es) "un procedimiento para preparar composiciones farmaceuticas a base de sales de teofilina y aminoacidos basicos".
Tanner The shaping art and vision of Howard O'Hagan: quest, belief and cycle in Tay John

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee